Beth Ashbridge is an associate in Goodwin’s Technology and Life Sciences group. Her practice focuses on commercialisation of intellectual property rights, particularly in the life sciences and technology sectors. Goodwin’s Technology and Life Sciences group advises on transactions, including licences, collaborations, distribution, manufacturing, outsourcing and R&D projects, as well as regulatory matters, contract and patent disputes, fundraisings, M&A transactions and IPOs.

Dr. Ashbridge also contributes to the firm's work in patent and commercial litigation, patent opinions and due diligence.

Dr. Ashbridge joined Goodwin in 2013 as a Science Advisor and later qualified as a J.D.. Since 2013, Dr. Ashbridge has been involved in several Hatch-Waxman and BPCIA patent litigation cases on both the brand and generic side. Dr. Ashbridge is also an active contributor to the firm’s biosimilars blog, Big Molecule Watch, which is dedicated to providing resources and observations through Goodwin’s active watch of the world of biologics, biosimilars and the Biologics Price Competition and Innovation Act (BPCIA). Dr. Ashbridge is an editor of Goodwin’s Guide to Biosimilars Litigation and Regulation in the U.S., which provides expert guidance and practical know-how for lawyers working in this burgeoning area of the law. Dr. Ashbridge is also a member of the firm’s specialist sectors: Late Stage Drug Development, FDA Litigation, and Life Science Disputes.

In 2019, Dr. Ashbridge graduated from the J.D. part-time evening program at Fordham University School of Law with honors (cum laude), and was extended the Paul Fuller Scholar Designation.

Dr. Ashbridge brings to her practice an exceptional combination of patent law expertise and technical proficiency in the pharmaceutical and biotechnology fields. Prior to joining Goodwin, Dr. Ashbridge carried out her graduate research in the Chemical Biology program at the Department of Chemistry, University of Cambridge, under the supervision of Sir Professor Shankar Balasubramanian. Following her graduate studies, Dr. Ashbridge worked under the guidance of Dr. Malcolm A.S. Moore as a Research Fellow in the Cell Biology Program at Memorial Sloan-Kettering Cancer Center in New York City.

Areas of Practice
Domaines D’Expertise

In The News









J.D., 2019
Fordham University School of Law
(cum laude; Paul Fuller Scholar; Activities: Urban Law Journal)
Ph.D., Chemical Biology, 2011
University of Cambridge
M.Sc., Natural Sciences, 2006
Durham University
Profile Image
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.


Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Search Other Lawyers
Recherche par Pratique